ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

The Dallas Morning News’ Groundbreaking Fentanyl Series Receives Accolades and National Notice

‘Deadly Fake’ Continues Comprehensive Coverage
Reports Detail Solutions with Effects on Families, Schools, Government

DALLAS, Sept. 19, 2023 (GLOBE NEWSWIRE) -- DallasNews Corporation (Nasdaq:DALN) -

Throughout this September, The Dallas Morning News continues to produce one story daily on fentanyl’s increasing path of unforgiving destruction. The ambitious series, for which more than two dozen News staffers are contributing, has been covered on CNN and produced praise for its work.

Deadly Fake: 30 Days Inside Fentanyl’s Grip on North Texas” tells the story of a prominent Dallas couple who lost their son to fentanyl. It looks at the rough street life of Brooklynn, an addict whose life is consumed by the readily available drug. How the Drug Enforcement Agency’s Dallas Field Division head remarks, “We’re only in the top of fentanyl’s second inning.” Take a ride-along to the front lines with Dallas Police Department officers and the head of the department’s narcotics division. And more stories and editorials are coming to round out the month.

Appearing on “CNN Newsroom with Jim Acosta” on Saturday, Sept. 9, News executive editor Katrice Hardy said, “For me and for our staff, the wake-up call really was news that three young people had died in a middle school right outside of Dallas in one school year. And more than a handful of others had overdosed – some multiple times. And it was just time to really step back and think what is going on in our community.”

Since the series debuted on Sept. 1, more than 100,000 online readers have consumed the stories and content. Readers have praised the reporting, calling it “a wake-up call,” “mandatory reading in middle schools and high schools,” and “this excellent reporting is what keeps me subscribing to The Dallas Morning News. This story will stay with me for a long time.”

The daily series wraps on Saturday, Sept. 30, but will be packaged and featured prominently on DallasNews.com. The Texas Legislature has designated October as Fentanyl Poisoning Awareness Month to increase awareness of the dangers of fentanyl and potential overdoses.

Dallas Morning News Resources

Series home: dallasnews.com/deadlyfake
Series home in Spanish: dallasnews.com/fentanilo
Instagram: @dallasnews
Facebook: @dallasmorningnews
Twitter: @dallasnews
TikTok: @dallasmorningnews
YouTube: @dallasnews

About DallasNews Corporation

DallasNews Corporation is the Dallas-based holding company of The Dallas Morning News and Medium Giant. The Dallas Morning News is Texas’ leading daily newspaper with a strong journalistic reputation, intense regional focus and close community ties. Medium Giant is a media and marketing agency of divergent thinkers who devise strategies that deepen connections, expand influence, and scale success for clients nationwide. For additional information, visit dallasnewscorporation.com or email invest@dallasnews.com

Contact:
Katrice Hardy, executive editor, The Dallas Morning News
katrice.hardy@dallasnews.com


Primary Logo

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.